![Dose Escalation and Pharmacokinetics Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma]()
Dose Escalation and Pharmacokinetics Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell CarcinomaSchmidinger, Manuela; Szczylik, Cezary; Sternberg, Cora N.; Kania, Marek; Kelly, Claudia Sue; Decker, Rodney; Hamid, Oday; Faelker, Taron; Escudier, Bernard · American Journal of Clinical Oncology · 2012